228 related articles for article (PubMed ID: 18263689)
1. Clinical utility of the QuantiFERON TB-2G test for elderly patients with active tuberculosis.
Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Okimoto N; Matsushima T; Kageoka T; Oka M
Chest; 2008 May; 133(5):1196-202. PubMed ID: 18263689
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of a T cell-based assay in the diagnosis of extrapulmonary tuberculosis.
Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Oka M
Respirology; 2009 Mar; 14(2):276-81. PubMed ID: 19210655
[TBL] [Abstract][Full Text] [Related]
3. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
4. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
Harada N
Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of QuantiFERON TB-2G test in patients with healed pulmonary tuberculosis.
Kobashi Y; Shimizu H; Mouri K; Obase Y; Miyashita N; Oka M
J Infect Chemother; 2009 Oct; 15(5):288-92. PubMed ID: 19856066
[TBL] [Abstract][Full Text] [Related]
6. Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis.
Kobashi Y; Obase Y; Fukuda M; Yoshida K; Miyashita N; Oka M
Clin Infect Dis; 2006 Dec; 43(12):1540-6. PubMed ID: 17109285
[TBL] [Abstract][Full Text] [Related]
7. [Application and problems of quantiFERON TB-2G for tuberculosis control programs--(2) clinical use of quantiFERON TB-2G].
Kawabe Y
Kekkaku; 2007 Jan; 82(1):61-6. PubMed ID: 17310783
[TBL] [Abstract][Full Text] [Related]
8. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
Sato S; Nagai H
Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of an in vitro assay for interferon gamma production in response to the Mycobacterium tuberculosis-synthesized peptide antigens ESAT-6 and CFP-10 and the PPD skin test.
Taggart EW; Hill HR; Ruegner RG; Litwin CM
Am J Clin Pathol; 2006 Mar; 125(3):467-73. PubMed ID: 16613353
[TBL] [Abstract][Full Text] [Related]
10. [The evaluation of the utility of QuantiFERON TB-Gold In-Tube; QFT-GIT].
Matsumoto T; Yamazaki T
Kekkaku; 2014 Sep; 89(9):743-55. PubMed ID: 25730946
[TBL] [Abstract][Full Text] [Related]
11. Detecting a low prevalence of latent tuberculosis among health care workers in Denmark detected by M. tuberculosis specific IFN-gamma whole-blood test.
Soborg B; Andersen AB; Larsen HK; Weldingh K; Andersen P; Kofoed K; Ravn P
Scand J Infect Dis; 2007; 39(6-7):554-9. PubMed ID: 17577817
[TBL] [Abstract][Full Text] [Related]
12. QuantiFERON TB-2G test for patients with active tuberculosis stratified by age groups.
Kobashi Y; Mouri K; Miyashita N; Okimoto N; Matsushima T; Kageoka T; Oka M
Scand J Infect Dis; 2009; 41(11-12):841-6. PubMed ID: 19922066
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients.
Kobashi Y; Mouri K; Obase Y; Fukuda M; Miyashita N; Oka M
Eur Respir J; 2007 Nov; 30(5):945-50. PubMed ID: 17652312
[TBL] [Abstract][Full Text] [Related]
14. Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice.
Kobashi Y; Sugiu T; Mouri K; Obase Y; Miyashita N; Oka M
Eur Respir J; 2009 Apr; 33(4):812-5. PubMed ID: 19129287
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of QuantiFERON®-TB Gold in Tube Test and Tuberculin Skin Test in the diagnosis of Mycobacterium tuberculosis infection].
Çavuşoğlu C; Durusoy R; Yaşar M; Kayın M
Mikrobiyol Bul; 2017 Apr; 51(2):115-126. PubMed ID: 28566075
[TBL] [Abstract][Full Text] [Related]
16. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States.
Mazurek GH; Jereb J; Lobue P; Iademarco MF; Metchock B; Vernon A;
MMWR Recomm Rep; 2005 Dec; 54(RR-15):49-55. PubMed ID: 16357824
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis.
Ravn P; Munk ME; Andersen AB; Lundgren B; Lundgren JD; Nielsen LN; Kok-Jensen A; Andersen P; Weldingh K
Clin Diagn Lab Immunol; 2005 Apr; 12(4):491-6. PubMed ID: 15817755
[TBL] [Abstract][Full Text] [Related]
18. Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment.
Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Oka M
J Infect; 2009 Mar; 58(3):197-204. PubMed ID: 18848730
[TBL] [Abstract][Full Text] [Related]
19. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M
J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
[TBL] [Abstract][Full Text] [Related]
20. Comparison of T-cell interferon-gamma release assays for Mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis.
Kobashi Y; Shimizu H; Ohue Y; Mouri K; Obase Y; Miyashita N; Oka M
Lung; 2010 Aug; 188(4):283-7. PubMed ID: 20422203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
